Posted by Site Administrator on June 19, 2012
“Identification of the dSarm/Sarm1 gene has enormous therapeutic potential, for example as a knockdown target for patients suffering from diseases involving axonal loss.”
Categories: Research News, Treatments
|
Tags: A. Nicole Fox, ALS, ALS community, ALS cure, ALS medical care, ALS research, amyotrophic lateral sclerosis, AXON, axonal degeneration, Bob Stehlin, Drosophila mutants, dSarm/Sarm1, Howard Hughes Medical Institute Early Career Scientist, Jeannette M. Osterloh, Jennifer M. MacDonald, Jennifer S. Zeigenfuss, loss-of-function alleles, Lou Gehrig's disease, Marc R Freeman, Mary A. Logan, Michelle A. Avery, Rachel Hackett, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig’s Disease amotrophic lateral sclerosis, UMass Medical School, Wallerian degeneration (Wlds)
|
No comments